» Articles » PMID: 38674791

Supplementation Prevents Intestinal Barrier Injury and Gut Microflora Dysbiosis Induced by Sleep Deprivation

Overview
Journal Nutrients
Date 2024 Apr 27
PMID 38674791
Authors
Affiliations
Soon will be listed here.
Abstract

Sleep deprivation (SD) leads to impaired intestinal barrier function and intestinal flora disorder, especially a reduction in the abundance of the next generation of probiotic (). However, it remains largely unclear whether can ameliorate SD-induced intestinal barrier damage. A 72 h SD mouse model was used in this research, with or without the addition of . The findings indicated that pre-colonization with could protect against tissue damage from SD, enhance goblet cell count and MUC2 levels in the colon, boost tight-junction protein expression, decrease macrophage infiltration, suppress pro-inflammatory cytokine expression, and reduce apoptosis. We found that the presence of helped to balance the gut microbiota in SD mice by reducing harmful bacteria like and , while increasing beneficial bacteria such as . Ion chromatography analysis revealed that pretreatment increased the fecal butyrate level in SD mice. Overall, these results suggested that incorporating could help reduce gut damage caused by SD, potentially by enhancing the intestinal barrier and balancing gut microflora. This provides a foundation for utilizing probiotics to protect against intestinal illnesses.

Citing Articles

Microbiome-Based Therapeutics for Insomnia.

Li C, Chen S, Wang Y, Su Q Int J Mol Sci. 2024; 25(23).

PMID: 39684918 PMC: 11642687. DOI: 10.3390/ijms252313208.


Modifications in the Composition of the Gut Microbiota in Rats Induced by Chronic Sleep Deprivation: Potential Relation to Mental Disorders.

Zheng L, Li Y Nat Sci Sleep. 2024; 16:1313-1325.

PMID: 39247907 PMC: 11380879. DOI: 10.2147/NSS.S476691.

References
1.
Wasfi R, Hamed S, Amer M, Fahmy L . Biofilm: Development and Therapeutic Strategies. Front Cell Infect Microbiol. 2020; 10:414. PMC: 7456845. DOI: 10.3389/fcimb.2020.00414. View

2.
Pedersen T, Brown E, Plichta D, Johansen J, Twardus S, Delorey T . The CD4 T cell response to a commensal-derived epitope transitions from a tolerant to an inflammatory state in Crohn's disease. Immunity. 2022; 55(10):1909-1923.e6. PMC: 9890645. DOI: 10.1016/j.immuni.2022.08.016. View

3.
Carlsson A, Yakymenko O, Olivier I, Hakansson F, Postma E, Keita A . Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis. Scand J Gastroenterol. 2013; 48(10):1136-44. DOI: 10.3109/00365521.2013.828773. View

4.
Singh V, Lee G, Son H, Koh H, Kim E, Unno T . Butyrate producers, "The Sentinel of Gut": Their intestinal significance with and beyond butyrate, and prospective use as microbial therapeutics. Front Microbiol. 2023; 13:1103836. PMC: 9877435. DOI: 10.3389/fmicb.2022.1103836. View

5.
Chen Y, Liu Y, Wang Y, Chen X, Wang C, Chen X . Prevotellaceae produces butyrate to alleviate PD-1/PD-L1 inhibitor-related cardiotoxicity via PPARα-CYP4X1 axis in colonic macrophages. J Exp Clin Cancer Res. 2022; 41(1):1. PMC: 8722009. DOI: 10.1186/s13046-021-02201-4. View